The worldwide incidence and prevalence of primary brain tumors: A systematic review and meta-analysis

Neuro-Oncology

Volumn 17, Issue 6, 2015, Pages 776-783

  De Robles, Paula ^a,b   Fiest, Kirsten M ^a,b   Frolkis, Alexandra D ^a   Pringsheim, Tamara ^a,b   Atta, Callie ^a   St Germaine Smith, Christine ^a   Day, Lundy ^a   Lam, Darren ^a,b   Jette, Nathalie ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Brain tumor; Incidence; Meta analysis; Prevalence; Systematic review

Indexed keywords

AFRICA; AGE; ASIA; AUSTRALIA; BRAIN CANCER; BRAIN TUMOR; CHOROID PLEXUS TUMOR; EUROPE; GERM CELL TUMOR; GLIOMA; HEMANGIOBLASTOMA; HUMAN; INCIDENCE; MEDICAL RESEARCH; MEDULLOBLASTOMA; MENINGIOMA; NERVE SHEATH TUMOR; NEUROECTODERM TUMOR; NORTH AMERICA; PINEAL BODY TUMOR; POPULATION RESEARCH; PREVALENCE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; REVIEW; SELLA TURCICA TUMOR; SEX DIFFERENCE; SOUTH AMERICA; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; BRAIN NEOPLASMS; CROSS-SECTIONAL STUDY; FEMALE; MALE; META ANALYSIS;

AGE FACTORS; BRAIN NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; PREVALENCE; SEX FACTORS;

EID: 84943147136     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou283     Document Type: Review

References (62)

1. Lacy J, Saadati H, Yu J. Complications of brain tumors and their treatment. Hemat Oncol Clin North Am. 2012;26(4):779-796.
2. Jacques G, Cormac O. Central nervous system tumors. Handb Clin Neurol. 2013;112:931-958.
3. Counsell C, Grant R. Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results. J Neurooncol. 1998;37(3):241-250.
4. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.
5. Boyle MH. Guidelines for evaluating prevalence studies. Evid Based Mental Health. 1998;1:37-39.
6. Loney PL, Chambers LW, Bennett KJ, et al. Critical appraisal of health literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19(4):170-176.
7. Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab. 2006;91(12):4769-4775.
8. Fernandez A, Karavitaki N, Wass JAH. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2010;72(3):377-382.
9. Al-Sheyyab M, Bateiha A, El Kayed S, et al. The incidence of childhood cancer in Jordan: a population-based study. Ann Saudi Med. 2003;23(5):260-263.
10. Alston RD, Newton R, Kelsey A, et al. Childhood medulloblastoma in northwest England 1954 to 1997: incidence and survival. Dev Med Child Neurol. 2003;45(5):308-314.
11. Berger C, Trombert-Paviot B, Mitton N, et al. [Childhood cancer incidence and survival rates in the Rhone-Alpes regional paediatric registry 1987-1999] [in French]. Arch Pediatr. 2006;13(2):121-129.
12. Birch JM, Alston RD, Kelsey AM, et al. Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer. 2002;87(11):1267-1274.
13. Brown M, Schrot R, Bauer K, et al. Incidence of first primary central nervous system tumors in California, 2001-2005: children, adolescents and teens. J Neurooncol. 2009;94(2):263-273.
14. Chakrabarti I, Cockburn M, Cozen W, et al. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer. 2005;104(12):2798-2806.
15. Chan M-Y, Teo W-Y, Seow W-T, et al. Epidemiology, management and treatment outcome of medulloblastoma in singapore. Ann Acad Med Singapore. 2007;36(5):314-318.
16. Christensen HC, Kosteljanetz M, Johansen C. Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery. 2003;52(6):1327-1333; discussion 1333-1324.
17. Cordera S, Bottacchi E, D'Alessandro G, et al. Epidemiology of primary intracranial tumors in NW Italy, a population based study: stable incidence in the last two decades. J Neurol. 2002;249(3):281-284.
18. Corn BW, Marcus SM, Topham A, et al. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer. 1997;79(12):2409-2413.
19. D'Alessandro G, Di Giovanni M, Iannizzi L, et al. Epidemiology of primary intracranial tumors in the Valle d'Aosta (Italy) during the 6-year period 1986-1991. Neuroepidemiology. 1995;14(3):139-146.
20. Davis FG, Kupelian V, Freels S, et al. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol. 2001;3(3):152-158.
21. Dobec-Meic B, Pikija S, Cvetko D, et al. Intracranial tumors in adult population of the Varazdin County (Croatia) 1996-2004: a population-based retrospective incidence study. J Neurooncol. 2006;78(3):303-310.
22. Dreifaldt AC, Carlberg M, Hardell L. Increasing incidence rates of childhood malignant diseases in Sweden during the period 1960-1998. Eur J Cancer. 2004;40(9):1351-1360.
23. Elia-Pasquet S, Provost D, Jaffre A, et al. Incidence of central nervous system tumors in Gironde, France. Neuroepidemiology. 2004;23(3):110-117.
24. Farinotti M, Ferrarini M, Solari A, et al. Incidence and survival of childhood CNS tumors in the Region of Lombardy, Italy. Brain. 1998;121(Pt 8):1429-1436.
25. Freedman LS, Barchana M, Al-Kayed S, et al. A comparison of population-based cancer incidence rates in Israel and Jordan. Eur J Cancer Prev. 2003;12(5):359-365.
26. Frohlich AM, Sutherland GR. Epidemiology and clinical features of vestibular schwannoma in Manitoba, Canada. Can J Neurol Sci. 1993;20(2):126-130.
27. Giordana MT, Schiffer P, Lanotte M, et al. Epidemiology of adult medulloblastoma. Int J Cancer. 1999;80(5):689-692.
28. Gurney JG, Wall DA, Jukich PJ, et al. The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes Control. 1999;10(2):101-105.
29. Jakab Z, Balogh E, Kiss C, et al. Epidemiologic studies in a population-based childhood cancer registry in Northeast Hungary. Med Pediatr Oncol. 2002;38(5):338-344.
30. Kaatsch P, Haaf G, Michaelis J. Childhood malignancies in Germany - methods and results of a nationwide registry. Eur J Cancer. 1995;31A(6):993-999.
31. Kaye AH, Giles GG, Gonzales M. Primary central nervous system tumors in Australia: a profile of clinical practice from the Australian Brain Tumor Register. Aust N Z J Surg. 1993;63(1):33-38.
32. Klaeboe L, Lonn S, Scheie D, et al. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer. 2005;117(6):996-1001.
33. Kuratsu J, Takeshima H, Ushio Y. Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int J Clin Oncol. 2001;6(4):183-191.
34. Lee CH, Jung KW, Yoo H, et al. Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc. 2010;48(2):145-152.
35. Liigant A, Asser T, Kulla A, et al. Epidemiology of primary central nervous system tumors in Estonia. Neuroepidemiology. 2000;19(6):300-311.
36. Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer. 2008;112(2):416-432.
37. Makino K, Nakamura H, Yano S, et al. Population-based epidemiological study of primary intracranial tumors in childhood. Childs Nerv Syst. 2010;26(8):1029-1034.
38. McKinney PA, Parslow RC, Lane SA, et al. Epidemiology of childhood brain tumors in Yorkshire, UK, 1974-95: geographical distribution and changing patterns of occurrence. Br J Cancer. 1998;78(7):974-979.
39. McNally RJ, Kelsey AM, Cairns DP, et al. Temporal increases in the incidence of childhood solid tumors seen in Northwest England (1954-1998) are likely to be real. Cancer. 2001;92(7):1967-1976.
40. McNeil DE, Cot TR, Clegg L, et al. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results. Med Pediatr Oncol. 2002;39(3):190-194.
41. Nielsen MS, Christensen HC, Kosteljanetz M, et al. Incidence of and survival from oligodendroglioma in Denmark, 1943-2002. Neuro Oncol. 2009;11(3):311-317.
42. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, et al. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab. 2000;85(4):1420-1425.
43. Pekmezovic T, Golubicic I, Grujicic D, et al. Incidence of primary central nervous system tumors among children in Belgrade (Serbia), 1991-2004. Pediatr Hematol Oncol. 2009;26(5):332-337.
44. Peris-Bonet R, Martinez-Garcia C, Lacour B, et al. Childhood central nervous system tumors - incidence and survival in Europe (1978-1997): report from Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2064-2080.
45. Pobereskin LH, Chadduck JB. Incidence of brain tumors in two English counties: a population based study. J Neurol Neurosurg Psychiatry. 2000;69(4):464-471.
46. Quoc NM, Hung NC, Kramarova E, et al. Incidence of childhood cancer in Ho Chi Minh City, Vietnam, 1995-97. Paediatr Perinat Epidemiol. 2000;14(3):240-247.
47. Seedat RY, Claassen AJ, Mol DA. Incidence and management of acoustic neuromas in South Africa. Otol Neurotol. 2002;23(6):996-998.
48. Shugg D, Allen BJ, Blizzard L, et al. Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer. 1994;59(6):765-770.
49. Stiller CA, Desandes E, Danon SE, et al. Cancer incidence and survival in European adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2006-2018.
50. Villano JL, Virk IY, Ramirez V, et al. Descriptive epidemiology of central nervous system germ cell tumors: nonpineal analysis. Neuro Oncol. 2010;12(3):257-264.
51. Werner MH, Phuphanich S, Lyman GH. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer. 1995;76(9):1634-1642.
52. Wohrer A, Waldhor T, Heinzl H, et al. The Austrian Brain Tumor Registry: a cooperative way to establish a population-based brain tumor registry. J Neurooncol. 2009;95(3):401-411.
53. Wu XC, Chen VW, Steele B, et al. Cancer incidence in adolescents and young adults in the United States, 1992-1997. J Adolesc Health. 2003;32(6):405-415.
54. Counsell CE, Collie DA, Grant R. Incidence of intracranial tumors in the Lothian region of Scotland, 1989-90. J Neurol Neurosurg Psychiatry. 1996;61(2):143-150.
55. Kaatsch P, Rickert CH, Kuhl J, et al. Population-based epidemiologic data on tumors in German children. Cancer. 2001;92(12):3155-3164.
56. Lacour B, Guyot-Goubin A, Guissou S, et al. Incidence of childhood cancer in France: National Children Cancer Registries, 2000-2004. Eur J Cancer Prev. 2010;19(3):173-181.
57. Miltenburg D, Louw DF, Sutherland GR. Epidemiology of childhood brain tumors. Can J Neurol Sci. 1996;23(2):118-122.
58. Davis FG, Malinski N, Haenszel W, et al. Primary brain tumor incidence rates in four United States regions, 1985-1989: A pilot study. Neuroepidemiology. 1996;15(2):103-112.
59. Porter KR, McCarthy BJ, Freels S, et al. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol. 2010;12(6):520-527.
60. Jazayeri S, Rahimi-Movaghar V, Shokraneh F, et al. Epidemiology of primary CNS tumors in Iran: a systematic review. Asian Pac J Cancer Prev. 2013;14(6):3979-3985.
61. Fisher JL, Schwartzbaum J, Wrensch M, et al. Epidemiology of brain tumors. Neurol Clin. 2007;25(4):867-890.
62. Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4(4):278-299.